Clinical Trial Update: The Safety And Efficacy Of Maintenance Therapy With CP-690,550 [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for maintenance therapy with tofacitinib (CP-690,550) in Crohn's disease, including safety and efficacy findi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-01-09